Form 8-K: 2012 Annual Meeting Results


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549
_____________________________________________________________________


FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 
______________________________________________________________________

Date of Report (Date of earliest event reported): May 8, 2012

BOSTON SCIENTIFIC CORPORATION
(Exact name of registrant as specified in its charter)

DELAWARE
1-11083
04-2695240
(State or other
(Commission
(IRS employer
jurisdiction of
file number)
identification no.)
incorporation)
 
 

One Boston Scientific Place, Natick, Massachusetts
01760-1537
(Address of principal executive offices)
(Zip code)

Registrant's telephone number, including area code:   (508) 650-8000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))






Item 5.07.     Submission of Matters to a Vote of Security Holders.

(a)    Boston Scientific Corporation (the “Company”) held its 2012 Annual Meeting of Stockholders (the “Annual Meeting”) on May 8, 2012 in Boston, Massachusetts.
 
(b)    The final voting results on each of the matters submitted to a vote of stockholders at the Annual Meeting are set forth below.

(1)    
The following nominees were elected to the Company's Board of Directors for a one-year term to hold office until the Company's 2013 Annual Meeting of Stockholders and until their successors have been elected and qualified.

Nominee
For
Withheld
Broker Non-Votes
Katharine T. Bartlett
1,091,717,200
49,032,545
94,574,629
Bruce L. Byrnes
1,124,089,951
16,659,794
94,574,629
Nelda J. Connors
1,126,675,537
14,074,208
94,574,629
Kristina M. Johnson
1,091,826,305
48,923,440
94,574,629
William H. Kucheman
1,119,743,448
21,006,297
94,574,629
Ernest Mario
1,088,561,745
52,188,000
94,574,629
N.J. Nicholas, Jr.
1,075,773,390
64,976,355
94,574,629
Pete M. Nicholas
1,072,364,341
68,385,404
94,574,629
Uwe E. Reinhardt
1,125,642,591
15,107,154
94,574,629
John E. Sununu
1,126,169,598
14,580,147
94,574,629
         

(2)    
The advisory vote on the compensation for the Company's “Named Executive Officers” as disclosed in the Company's proxy statement for the Annual Meeting was approved. 

For
Against
Abstain
Broker Non-Votes
804,149,315
332,396,800
4,203,630
94,574,629
 
 
(3)    
The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the 2012 fiscal year was ratified.
  
For
Against
Abstain
Broker Non-Votes
1,226,894,147
7,197,761
1,232,466
0


(4)    
The amendment and restatement of the Company's By-Laws to provide for a majority vote standard in uncontested director elections was not approved.
 
For
Against
Abstain
Broker Non-Votes
1,132,288,503
6,860,171
1,601,071
94,574,629







SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
                        
                                
Date: May 14, 2012
BOSTON SCIENTIFIC CORPORATION
 
 
 
 
 
 
By:
/s/ Vance R. Brown
 
 
 
Vance R. Brown
 
 
 
Vice President and Chief Corporate Counsel